Moreover, due to the relatively speculative nature of computational studies, in vitro and in vivo assays are warranted to experimentally validate the predicted CA5A inhibitory activity of rosmarinic acid and chlorogenic acid and to thoroughly evaluate the anti-obesity and lipid-lowering activities of the assessed plant extracts. Here, CA5A is linked to obesity disorder.